When stimulated in vitro via a two-signal model of activation through the BCR and CD40, B cells of MS patients produce more lymphotoxin (LT) and tumor necrosis factor α (TNFα) compared to healthy controls, too [8]. Here, CD40 is linked to myeloid sarcoma.